Celleron Therapeutics
Celleron Therapeutics was a clinical-stage Oxford University spinout focussed on the clinical development of new drugs against unmet cancers. In late 2022, it merged with Argonaut Therapeutics to form IngenOx Therapeutics. Celleron’s Vision is to build a global pipeline of clinical products which are safe and effective in unmet indications, supported by a precision medicine platform.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
1 to 10
headcount range
Open roles
—
no listings
Distinct roles
0
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Celleron Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Sign up to unlock all 1 contacts at Celleron Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Celleron Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.